KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Average: 2016-2025

Historic Equity Average for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $233.0 million.

  • Medpace Holdings' Equity Average fell 71.67% to $233.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.0 million, marking a year-over-year decrease of 71.67%. This contributed to the annual value of $692.2 million for FY2024, which is 46.46% up from last year.
  • Medpace Holdings' Equity Average amounted to $233.0 million in Q3 2025, which was down 39.16% from $383.0 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Equity Average ranged from a high of $925.5 million in Q4 2021 and a low of $233.0 million during Q3 2025.
  • Moreover, its 3-year median value for Equity Average was $514.9 million (2023), whereas its average is $546.9 million.
  • Its Equity Average has fluctuated over the past 5 years, first spiked by 94.38% in 2024, then crashed by 71.67% in 2025.
  • Quarterly analysis of 5 years shows Medpace Holdings' Equity Average stood at $925.5 million in 2021, then tumbled by 60.22% to $368.1 million in 2022, then skyrocketed by 39.88% to $514.9 million in 2023, then spiked by 65.75% to $853.5 million in 2024, then crashed by 71.67% to $233.0 million in 2025.
  • Its Equity Average was $233.0 million in Q3 2025, compared to $383.0 million in Q2 2025 and $709.6 million in Q1 2025.